Back to Results
First PageMeta Content
Biology / Diabetes / Thiazolidinediones / Amides / Nateglinide / Anti-diabetic medication / Insulin / Hypoglycemia / Blood sugar / Endocrine system / Medicine / Eli Lilly and Company


November 30, 2006 SNDA FOR A FAST-ACTING POSTPRANDIAL HYPOGLYCEMIC AGENT FASTIC® TABLET / STARSIS® TABLET FOR COMBINATION THERAPY WITH INSULIN SENSITIZER WAS FILED November 30, [removed]Tokyo - Ajinomoto Co., Inc. (Headq
Add to Reading List

Document Date: 2008-09-19 00:23:23

Open Document

File Size: 9,83 KB

Share Result on Facebook

City

Tokyo / Basel / Seoul / /

Company

Ildong Pharmaceutical Co. Ltd. / Novartis Pharma AG / Sankyo Co. Ltd. / Astellas Pharma Inc. / Ajinomoto Co. Inc. / /

Country

Switzerland / Japan / South Korea / United States / /

Event

FDA Phase / /

/

MedicalCondition

diabetes / /

Person

Norio Yamaguchi / Masafumi Nogimori / /

/

Position

President & CEO / /

Product

Pioglitazone / FASTIC Tablet / STARSIS Tablet / nateglinide / Tablet / STARSIS Tablet / FASTIC Tablet / STARSIS Tablet / /

Technology

alpha / /

URL

http /

SocialTag